SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AC0. A total of 22 filers reported holding SALIX PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $44,618,000 | +50.0% | 12,000,000 | 0.0% | 0.02% | +53.8% |
| Q4 2014 | $29,738,000 | -26.3% | 12,000,000 | 0.0% | 0.01% | -27.8% |
| Q3 2014 | $40,328,000 | +25.5% | 12,000,000 | 0.0% | 0.02% | +28.6% |
| Q2 2014 | $32,123,000 | -5.7% | 12,000,000 | -30.6% | 0.01% | -17.6% |
| Q4 2013 | $34,071,000 | +28.9% | 17,290,000 | 0.0% | 0.02% | +21.4% |
| Q3 2013 | $26,432,000 | +1.3% | 17,290,000 | +0.6% | 0.01% | -6.7% |
| Q2 2013 | $26,104,000 | – | 17,190,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 219,440,000 | $585,836,000 | 7.18% |
| SYMPHONY ASSET MANAGEMENT LLC | 11,727,000 | $31,333,000 | 3.26% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 28,200,000 | $75,347,000 | 0.92% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,943,000 | $31,896,000 | 0.70% |
| DINSMORE CAPITAL MANAGEMENT CO/NJ | 600,000 | $1,606,000 | 0.62% |
| BNP PARIBAS FINANCIAL MARKETS | 1,200,000 | $320,628,000,000 | 0.30% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 3,000,000 | $7,998,000 | 0.10% |
| Visium Asset Management, LP | 2,000,000 | $5,335,000 | 0.08% |
| SG Americas Securities, LLC | 22,800 | $6,103,000 | 0.04% |
| LORD, ABBETT & CO. LLC | 10,988,000 | $29,414,000 | 0.03% |